These are often mild and temporary but should be discussed with your doctor
Additionally, the product composition may vary between batches , as indicated by reports of inconsistencies from Swissmedic
4.1 Trial evidence: recording and limitations of taste-related outcomes in RCTs and PROs In randomised controlled trials (RCTs), primary outcomes are typically focused on body weight and metabolic endpoints, whereas eating-experience-related outcomes are rarely included as prespecified measures and are more often captured only sporadically as adverse events (AEs) (69)
Its main actions include: Stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner Suppressing glucagon release, which reduces hepatic glucose production Slowing gastric emptying, which moderates post-meal glucose spikes Promoting satiety through central nervous system pathways, thereby reducing appetite GIP is released by K-cells in the proximal small intestine and shares some functions with GLP-1, particularly in enhancing insulin secretion after meals
They might adjust the dosage or suggest medications to ease common symptoms